Table 3.
Minimum inhibitory concentrations of crude extracts of secondary metabolites from bacterial endophytes associated with Dicoma anomala.
| Pathogenic test strains | |||||
|---|---|---|---|---|---|
| E. coli (ATCC25922) | B. cereus (ATCC10876) | S. aureus (NCTC6571) | P. aeruginosa (ATCC27853) | K. oxytoca (ATCC13182) | |
| Bacterial Endophyte's crude extracts | MIC (mg/mL) | ||||
| Stenotrophomonas sp. strain MHSD20 | 2.5 | 0.625 | 2.5 | 1.25 | 5 |
| Enterobacter sp. strain MHSD22 | 2.5 | 5 | 2.5 | 5 | 10 |
| Staphylococcus sp. strain MHSD26 | 5 | 0.625 | 0.312 | 2.5 | 10 |
| Bacillus sp. strain MHSD28 | 0.625 | 2.5 | 0.312 | 2.5 | 2.5 |
| Stenotrophomonas sp. strain MHSD12 | 1.25 | 0.625 | 2.5 | 0.625 | 5 |
| Bacillus sp. strain MHSD14 | 5 | 0.312 | 1.25 | 5 | 2.5 |
| Pantoea sp. strain MHSD15 | 1.25 | 2.5 | 0.625 | 2.5 | 10 |
∗Streptomycin (positive control) inhibited all the test strains at 1 mg/mL.